These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17224929)

  • 1. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
    Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
    Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
    Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
    Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
    Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
    Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
    Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH
    Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
    Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
    Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
    Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
    Blüher M; Engeli S; Klöting N; Berndt J; Fasshauer M; Bátkai S; Pacher P; Schön MR; Jordan J; Stumvoll M
    Diabetes; 2006 Nov; 55(11):3053-60. PubMed ID: 17065342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
    Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
    Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
    Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating anandamide and blood pressure in patients with obstructive sleep apnea.
    Engeli S; Blüher M; Jumpertz R; Wiesner T; Wirtz H; Bosse-Henck A; Stumvoll M; Batkai S; Pacher P; Harvey-White J; Kunos G; Jordan J
    J Hypertens; 2012 Dec; 30(12):2345-51. PubMed ID: 23032139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the peripheral endocannabinoid system in human obesity.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Janke J; Bátkai S; Pacher P; Harvey-White J; Luft FC; Sharma AM; Jordan J
    Diabetes; 2005 Oct; 54(10):2838-43. PubMed ID: 16186383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.
    Annuzzi G; Piscitelli F; Di Marino L; Patti L; Giacco R; Costabile G; Bozzetto L; Riccardi G; Verde R; Petrosino S; Rivellese AA; Di Marzo V
    Lipids Health Dis; 2010 Apr; 9():43. PubMed ID: 20426869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
    Matias I; Gonthier MP; Orlando P; Martiadis V; De Petrocellis L; Cervino C; Petrosino S; Hoareau L; Festy F; Pasquali R; Roche R; Maj M; Pagotto U; Monteleone P; Di Marzo V
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3171-80. PubMed ID: 16684820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.